Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastric (cardia, Body) Cancer”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Not applicableLooking for participantsNCT06731998
What this trial is testing

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

Who this might be right for
Oncologic SurgeryCancerCancer Surgery+8 more
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) 48
Not applicableLooking for participantsNCT06702683
What this trial is testing

The Correlation Between Blood Concentration of Sintilimab and Efficacy and Adverse Reactions in Patients with Advanced Gastric Cancer

Who this might be right for
Gastric CarcinomaGastric NeoplasmGastric (cardia, Body) Cancer+1 more
Lin Liu 112
Not applicableLooking for participantsNCT07114627
What this trial is testing

Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients

Who this might be right for
Solid CancerGastric (Cardia, Body) CancerEsophageal Cancer+1 more
Erasmus Medical Center 66
Large-scale testing (Phase 3)Looking for participantsNCT06028737
What this trial is testing

Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer

Who this might be right for
Gastric CancerStomach CancerGastroEsophageal Cancer+13 more
Ukrainian Society of Clinical Oncology 150
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07018063
What this trial is testing

Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) CancerStomach AdenocarcinomaLocally Advanced
zhoujing 35
Not applicableStudy completedNCT00341276
What this trial is testing

Esophageal Cancer Genetics Studies

Who this might be right for
Esophageal CancerGastric (Cardia, Body) Cancer
National Cancer Institute (NCI) 7,705
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06904300
What this trial is testing

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

Who this might be right for
Gastric (Cardia, Body) Cancer
Sun Yat-sen University 110
Testing effectiveness (Phase 2)Looking for participantsNCT07000253
What this trial is testing

Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma

Who this might be right for
Esophageal CancerGastric (Stomach) CancerGastric Adenocarcinoma+3 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 290
Large-scale testing (Phase 3)Looking for participantsNCT06768164
What this trial is testing

Quality of Life After Billroth II or Roux-en-Y for Gastric Cancer

Who this might be right for
Gastric (Cardia, Body) Cancer
Assistance Publique - Hôpitaux de Paris 250